SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-220846
Filing Date
2013-05-15
Accepted
2013-05-15 07:03:50
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d521143d10q.htm 10-Q 561031
2 EX-10.1 d521143dex101.htm EX-10.1 253143
3 EX-31.1 d521143dex311.htm EX-31.1 5893
4 EX-32.1 d521143dex321.htm EX-32.1 3031
  Complete submission text file 0001193125-13-220846.txt   3285348

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rxii-20130331.xml EX-101.INS 319080
6 XBRL TAXONOMY EXTENSION SCHEMA rxii-20130331.xsd EX-101.SCH 27191
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20130331_cal.xml EX-101.CAL 46251
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20130331_def.xml EX-101.DEF 177459
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20130331_lab.xml EX-101.LAB 266735
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20130331_pre.xml EX-101.PRE 208733
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54910 | Film No.: 13843679
SIC: 2834 Pharmaceutical Preparations